Westfield Capital Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-684,694	Closed	-$73.5M	–	254
2023 Q1	$73.5M	Buy	684,694 +366,520	+115%	+$39.3M	0.52%	66
2022 Q4	$35M	Buy	+318,174	New	+$35M	0.27%	126